Canada markets closed

RespireRx Pharmaceuticals Inc. (RSPI)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0010+0.0001 (+11.11%)
At close: 03:39PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 424.57k
Enterprise Value 4.01M
Trailing P/E 0.02
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.95

Trading Information

Stock Price History

Beta (5Y Monthly) 0.53
52-Week Change 3-70.97%
S&P500 52-Week Change 322.38%
52 Week High 30.0191
52 Week Low 30.0006
50-Day Moving Average 30.0010
200-Day Moving Average 30.0011

Share Statistics

Avg Vol (3 month) 38.95M
Avg Vol (10 day) 34.25M
Shares Outstanding 5471.74M
Implied Shares Outstanding 6576.57M
Float 8353.99M
% Held by Insiders 16.63%
% Held by Institutions 10.00%
Shares Short (Nov 30, 2009) 4126
Short Ratio (Nov 30, 2009) 41.47
Short % of Float (Nov 30, 2009) 40.61%
Short % of Shares Outstanding (Nov 30, 2009) 40.60%
Shares Short (prior month Oct 30, 2009) 4245

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 06, 2021
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jan 06, 2021

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-1,104.95%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-2.17M
Diluted EPS (ttm)-0.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.36k
Total Cash Per Share (mrq)0
Total Debt (mrq)2.78M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.01
Book Value Per Share (mrq)-0.04

Cash Flow Statement

Operating Cash Flow (ttm)-247.57k
Levered Free Cash Flow (ttm)-661.03k